Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 34351-34400 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06190184
Viome Precision Nutritional Programs to Improve Clinical Outcomes for Mental Health Conditions
NA
Recruiting
60 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2024
9 conditions
1 sponsor
1 location
NCT05985109
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
PHASE2
Recruiting
98 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06094582
Knowledges and Use of Cannabidiol in Older Adults
N/A
Recruiting
140 participants
Started: Oct 26, 2023 · Completed: May 31, 2024
2 conditions
1 sponsor
1 location
NCT05899608
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
PHASE3
Recruiting
1,080 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2028
1 condition
1 sponsor
219 locations
NCT06100328
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
N/A
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Jul 31, 2030
1 condition
1 sponsor
1 location
NCT06009523
Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation
NA
Recruiting
50 participants
Started: Oct 26, 2023 · Completed: Dec 1, 2027
1 condition
1 sponsor
2 locations
NCT05952271
Herpes Zoster Hospitalizations in Italy
N/A
Recruiting
72,000 participants
Started: Oct 26, 2023 · Completed: Jul 30, 2025
2 conditions
2 sponsors
1 location
NCT05440864
Durvalumab and Tremelimumab in Resectable HCC
PHASE2
Recruiting
28 participants
Started: Oct 26, 2023 · Completed: Nov 30, 2026
1 condition
3 sponsors
3 locations
NCT06225856
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies
PHASE1
Recruiting
96 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2026
2 conditions
1 sponsor
1 location
NCT06057376
Impact of Two Dietary Interventions on Simple Carbohydrate Intolerance
NA
Recruiting
40 participants
Started: Oct 26, 2023 · Completed: Feb 28, 2026
1 condition
3 sponsors
1 location
NCT06401850
Polycystic Ovary Syndrome and Education
NA
Recruiting
70 participants
Started: Oct 26, 2023 · Completed: Jun 30, 2024
1 condition
1 sponsor
1 location
NCT06019923
Study on the Dynamic Changes of Metabolic Biomarkers and Their Prognostic Relationship in Ovarian Cancer
N/A
Recruiting
100 participants
Started: Oct 26, 2023 · Completed: Sep 10, 2027
1 condition
1 sponsor
1 location
NCT06026319
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
PHASE1
Recruiting
24 participants
Started: Oct 26, 2023 · Completed: Jan 1, 2028
10 conditions
1 sponsor
1 location
NCT05674994
Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis
PHASE3
Recruiting
110 participants
Started: Oct 26, 2023 · Completed: Dec 31, 2026
1 condition
1 sponsor
29 locations
NCT06895291
Whole Body MRI in Oncology
N/A
Recruiting
1,000 participants
Started: Oct 26, 2023 · Completed: Oct 31, 2031
6 conditions
1 sponsor
3 locations
NCT05834244
A Phase Ib Trial of Azacitidine, Venetoclax and Allogeneic NK Cells for Acute Myeloid Leukemia (ADVENT-AML)
PHASE1
Recruiting
32 participants
Started: Oct 26, 2023 · Completed: Jun 30, 2028
1 condition
1 sponsor
2 locations
NCT06495281
Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus Patients
N/A
Recruiting
3,000 participants
Started: Oct 26, 2023 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05632406
Breathing & Blood Pressure
N/A
Recruiting
80 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT06028659
Investigation of in Vivo Endogenous and/or Exogenous Production of Phenolic Metabolites Using (un)Targeted Metabolomics
NA
Recruiting
30 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06075849
Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent
PHASE1
Recruiting
30 participants
Started: Oct 25, 2023 · Completed: Jan 31, 2025
6 conditions
1 sponsor
3 locations
NCT06223724
Status Telemetry for Cochlear Implantations
N/A
Recruiting
20 participants
Started: Oct 25, 2023 · Completed: Oct 1, 2024
1 condition
1 sponsor
1 location
NCT06567301
Extracorporeal Shockwave Versus Phonophoresis Using Chitosan-Nanoparticles Gel on Functional and Anatomical Changes Detected With Artificial Intelligence Based Texture Analysis Algorithm in Knee Osteoarthritis Patients: A Double Blind Randomized Controlled Trial
NA
Recruiting
120 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2025
5 conditions
1 sponsor
2 locations
NCT05763303
Impact of an Interventional Program on Self-Management
NA
Recruiting
300 participants
Started: Oct 25, 2023 · Completed: Oct 1, 2025
1 condition
1 sponsor
1 location
NCT05669378
A Good Start Matters Intervention Study
NA
Recruiting
52 participants
Started: Oct 25, 2023 · Completed: Sep 30, 2025
2 conditions
2 sponsors
1 location
NCT06904014
Efficacy and Safety of Sintilimab Combined With Lenvatinib and HAIC for Neoadjuvant Therapy of Borderline Resectable HCC
PHASE2
Recruiting
40 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2029
1 condition
1 sponsor
1 location
NCT06091423
XELOX Combined With Fruquintinib and Sintilimab Regimen Conversion Therapy for Gastric Cancer/Gastroesophageal Junction Adenocarcinoma Only With Liver and/or Retroperitoneal Lymph Node Metastasis, a Prospective Single-arm, Multicenter Study
PHASE2
Recruiting
43 participants
Started: Oct 25, 2023 · Completed: Nov 25, 2026
1 condition
1 sponsor
1 location
NCT06067516
Effects of Fluid Resuscitation on Capillary Refilling Time and Organ Functions in Septic Shock
N/A
Recruiting
40 participants
Started: Oct 25, 2023 · Completed: Mar 1, 2026
1 condition
1 sponsor
1 location
NCT05928039
PATHFINDER: Evaluating the Optimal First-Line Treatment Strategy for Moderate-to-Severely Active Ileal-dominant Crohn's Disease
PHASE4
Recruiting
297 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2028
1 condition
2 sponsors
20 locations
NCT06090955
Modulating Surgery-Induced Blood-Brain Barrier Disruption in Elderly
NA
Recruiting
108 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT06065631
Seeing to Learn in Sierra Leone
NA
Recruiting
2,400 participants
Started: Oct 25, 2023 · Completed: Jan 31, 2026
1 condition
4 sponsors
1 location
NCT05726331
Chronic Non-Specific Neck Pain Treated With Tai Chi and Chiropractic Care
NA
Recruiting
48 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT05484089
CapFlex PIP Implant RSA
N/A
Recruiting
36 participants
Started: Oct 25, 2023 · Completed: Oct 31, 2035
1 condition
1 sponsor
1 location
NCT06119685
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
PHASE1/PHASE2
Recruiting
128 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2029
7 conditions
1 sponsor
12 locations
NCT06027307
Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
PHASE3
Recruiting
540 participants
Started: Oct 25, 2023 · Completed: Oct 31, 2027
2 conditions
2 sponsors
5 locations
NCT06190639
A Clinical Study of Sintilimab as Adjuvant Therapy in Node-positive ESCC
PHASE2
Recruiting
31 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT06060613
Safety and Efficacy of OBX-115 in Advanced Solid Tumors
PHASE1/PHASE2
Recruiting
52 participants
Started: Oct 25, 2023 · Completed: Jun 30, 2028
7 conditions
1 sponsor
9 locations
NCT06059157
Epileptogenic Network Visualisation With Advanced MRI
NA
Recruiting
80 participants
Started: Oct 25, 2023 · Completed: Oct 31, 2029
1 condition
1 sponsor
1 location
NCT06176313
Effects of Training Given to Cope With Premenstrual Syndrome and Mandala Activity on Premenstrual Symptoms
NA
Recruiting
90 participants
Started: Oct 25, 2023 · Completed: Jan 31, 2024
1 condition
1 sponsor
1 location
NCT04244981
Efficacy of Prothrombin Complex Concentrate Reducing Perioperative Blood Loss in Cardiac Surgery
PHASE4
Recruiting
796 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2025
1 condition
5 sponsors
2 locations
NCT05980143
Metacognitive Therapy for Common Mental Health Problems in Autistic CYP: A Case Series
NA
Recruiting
5 participants
Started: Oct 25, 2023 · Completed: Apr 30, 2024
2 conditions
3 sponsors
2 locations
NCT06283433
A Dried Blood Spot Sampling Method for Vancomycin and Creatinine Monitoring for OPAT
NA
Recruiting
84 participants
Started: Oct 25, 2023 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT06096766
The Correlation Between Ovarian Function and Serum Biomarkers
N/A
Recruiting
35 participants
Started: Oct 25, 2023 · Completed: Nov 11, 2025
6 conditions
1 sponsor
1 location
NCT06073509
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
N/A
Recruiting
200 participants
Started: Oct 25, 2023 · Completed: Nov 20, 2025
5 conditions
4 sponsors
1 location
NCT06025578
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis
PHASE3
Recruiting
1,092 participants
Started: Oct 25, 2023 · Completed: Dec 27, 2027
1 condition
1 sponsor
536 locations
NCT05715619
Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy and VRE-Colonized Subjects
PHASE1/PHASE2
Recruiting
80 participants
Started: Oct 25, 2023 · Completed: Mar 31, 2025
1 condition
1 sponsor
1 location
NCT06354608
The Effect of Audio Book and Local Vibration on Pain and Fear in Intramuscular Injection in Children
NA
Recruiting
120 participants
Started: Oct 25, 2023 · Completed: Jul 1, 2024
1 condition
1 sponsor
1 location
NCT06864520
Evaluation of the Beneficial Effects of a Product Containing Γ-aminobutyric Acid (GABA) on Climacteric Syndrome Disorders
NA
Recruiting
112 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06008119
Efficacy and Safety of Tunlametinib Plus Vemurafenib in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer
PHASE3
Recruiting
165 participants
Started: Oct 25, 2023 · Completed: Dec 24, 2026
1 condition
1 sponsor
1 location
NCT05266040
Valacyclovir in Pain Management of Acute Apical Abscesses
PHASE2
Recruiting
60 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05178498
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
N/A
Recruiting
960 participants
Started: Oct 25, 2023 · Completed: Dec 31, 2035
5 conditions
1 sponsor
1 location
Previous
1
More pages
685
686
687
688
689
690
691
More pages
1333
Next